img

Global Pharmaceutical Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pharmaceutical Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
Pharmaceutical Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pharmaceutical Drugs market is projected to reach US$ 2075470 million in 2029, increasing from US$ 1475000 million in 2022, with the CAGR of 5.0% during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharmaceutical Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
AbbVie
Takeda
Boehringer Ingelheim
Takeda
Segment by Type
Brand Drugs
Generic Drug

Segment by Application


Hospital
Clinic
Other
By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pharmaceutical Drugs market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Pharmaceutical Drugs introduction, etc. Pharmaceutical Drugs Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Pharmaceutical Drugs market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Pharmaceutical Drugs
1.1 Pharmaceutical Drugs Market Overview
1.1.1 Pharmaceutical Drugs Product Scope
1.1.2 Pharmaceutical Drugs Market Status and Outlook
1.2 Global Pharmaceutical Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pharmaceutical Drugs Market Size by Region (2018-2029)
1.4 Global Pharmaceutical Drugs Historic Market Size by Region (2018-2024)
1.5 Global Pharmaceutical Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pharmaceutical Drugs Market Size (2018-2029)
1.6.1 North America Pharmaceutical Drugs Market Size (2018-2029)
1.6.2 Europe Pharmaceutical Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Pharmaceutical Drugs Market Size (2018-2029)
1.6.4 Latin America Pharmaceutical Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Pharmaceutical Drugs Market Size (2018-2029)
2 Pharmaceutical Drugs Market by Type
2.1 Introduction
2.1.1 Brand Drugs
2.1.2 Generic Drug
2.2 Global Pharmaceutical Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pharmaceutical Drugs Historic Market Size by Type (2018-2024)
2.2.2 Global Pharmaceutical Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pharmaceutical Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pharmaceutical Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pharmaceutical Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pharmaceutical Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pharmaceutical Drugs Revenue Breakdown by Type (2018-2029)
3 Pharmaceutical Drugs Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Other
3.2 Global Pharmaceutical Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pharmaceutical Drugs Historic Market Size by Application (2018-2024)
3.2.2 Global Pharmaceutical Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pharmaceutical Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pharmaceutical Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pharmaceutical Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pharmaceutical Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pharmaceutical Drugs Revenue Breakdown by Application (2018-2029)
4 Pharmaceutical Drugs Competition Analysis by Players
4.1 Global Pharmaceutical Drugs Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Drugs as of 2022)
4.3 Date of Key Players Enter into Pharmaceutical Drugs Market
4.4 Global Top Players Pharmaceutical Drugs Headquarters and Area Served
4.5 Key Players Pharmaceutical Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Pharmaceutical Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Pharmaceutical Drugs Products, Services and Solutions
5.1.4 Pfizer Pharmaceutical Drugs Revenue (US$ Million) & (2018-2024)
5.1.5 Pfizer Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Pharmaceutical Drugs Products, Services and Solutions
5.2.4 Roche Pharmaceutical Drugs Revenue (US$ Million) & (2018-2024)
5.2.5 Roche Recent Developments
5.3 Sanofi
5.3.1 Sanofi Profile
5.3.2 Sanofi Main Business
5.3.3 Sanofi Pharmaceutical Drugs Products, Services and Solutions
5.3.4 Sanofi Pharmaceutical Drugs Revenue (US$ Million) & (2018-2024)
5.3.5 Johnson & Johnson Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Profile
5.4.2 Johnson & Johnson Main Business
5.4.3 Johnson & Johnson Pharmaceutical Drugs Products, Services and Solutions
5.4.4 Johnson & Johnson Pharmaceutical Drugs Revenue (US$ Million) & (2018-2024)
5.4.5 Johnson & Johnson Recent Developments
5.5 Merck & Co. (MSD)
5.5.1 Merck & Co. (MSD) Profile
5.5.2 Merck & Co. (MSD) Main Business
5.5.3 Merck & Co. (MSD) Pharmaceutical Drugs Products, Services and Solutions
5.5.4 Merck & Co. (MSD) Pharmaceutical Drugs Revenue (US$ Million) & (2018-2024)
5.5.5 Merck & Co. (MSD) Recent Developments
5.6 Novartis
5.6.1 Novartis Profile
5.6.2 Novartis Main Business
5.6.3 Novartis Pharmaceutical Drugs Products, Services and Solutions
5.6.4 Novartis Pharmaceutical Drugs Revenue (US$ Million) & (2018-2024)
5.6.5 Novartis Recent Developments
5.7 AbbVie
5.7.1 AbbVie Profile
5.7.2 AbbVie Main Business
5.7.3 AbbVie Pharmaceutical Drugs Products, Services and Solutions
5.7.4 AbbVie Pharmaceutical Drugs Revenue (US$ Million) & (2018-2024)
5.7.5 AbbVie Recent Developments
5.8 Gilead Sciences
5.8.1 Gilead Sciences Profile
5.8.2 Gilead Sciences Main Business
5.8.3 Gilead Sciences Pharmaceutical Drugs Products, Services and Solutions
5.8.4 Gilead Sciences Pharmaceutical Drugs Revenue (US$ Million) & (2018-2024)
5.8.5 Gilead Sciences Recent Developments
5.9 GlaxoSmithKline (GSK)
5.9.1 GlaxoSmithKline (GSK) Profile
5.9.2 GlaxoSmithKline (GSK) Main Business
5.9.3 GlaxoSmithKline (GSK) Pharmaceutical Drugs Products, Services and Solutions
5.9.4 GlaxoSmithKline (GSK) Pharmaceutical Drugs Revenue (US$ Million) & (2018-2024)
5.9.5 GlaxoSmithKline (GSK) Recent Developments
5.10 Amgen
5.10.1 Amgen Profile
5.10.2 Amgen Main Business
5.10.3 Amgen Pharmaceutical Drugs Products, Services and Solutions
5.10.4 Amgen Pharmaceutical Drugs Revenue (US$ Million) & (2018-2024)
5.10.5 Amgen Recent Developments
5.11 AstraZeneca
5.11.1 AstraZeneca Profile
5.11.2 AstraZeneca Main Business
5.11.3 AstraZeneca Pharmaceutical Drugs Products, Services and Solutions
5.11.4 AstraZeneca Pharmaceutical Drugs Revenue (US$ Million) & (2018-2024)
5.11.5 AstraZeneca Recent Developments
5.12 Bristol-Myers Squibb
5.12.1 Bristol-Myers Squibb Profile
5.12.2 Bristol-Myers Squibb Main Business
5.12.3 Bristol-Myers Squibb Pharmaceutical Drugs Products, Services and Solutions
5.12.4 Bristol-Myers Squibb Pharmaceutical Drugs Revenue (US$ Million) & (2018-2024)
5.12.5 Bristol-Myers Squibb Recent Developments
5.13 Eli Lilly
5.13.1 Eli Lilly Profile
5.13.2 Eli Lilly Main Business
5.13.3 Eli Lilly Pharmaceutical Drugs Products, Services and Solutions
5.13.4 Eli Lilly Pharmaceutical Drugs Revenue (US$ Million) & (2018-2024)
5.13.5 Eli Lilly Recent Developments
5.14 Teva
5.14.1 Teva Profile
5.14.2 Teva Main Business
5.14.3 Teva Pharmaceutical Drugs Products, Services and Solutions
5.14.4 Teva Pharmaceutical Drugs Revenue (US$ Million) & (2018-2024)
5.14.5 Teva Recent Developments
5.15 Bayer
5.15.1 Bayer Profile
5.15.2 Bayer Main Business
5.15.3 Bayer Pharmaceutical Drugs Products, Services and Solutions
5.15.4 Bayer Pharmaceutical Drugs Revenue (US$ Million) & (2018-2024)
5.15.5 Bayer Recent Developments
5.16 Novo Nordisk
5.16.1 Novo Nordisk Profile
5.16.2 Novo Nordisk Main Business
5.16.3 Novo Nordisk Pharmaceutical Drugs Products, Services and Solutions
5.16.4 Novo Nordisk Pharmaceutical Drugs Revenue (US$ Million) & (2018-2024)
5.16.5 Novo Nordisk Recent Developments
5.17 AbbVie
5.17.1 AbbVie Profile
5.17.2 AbbVie Main Business
5.17.3 AbbVie Pharmaceutical Drugs Products, Services and Solutions
5.17.4 AbbVie Pharmaceutical Drugs Revenue (US$ Million) & (2018-2024)
5.17.5 AbbVie Recent Developments
5.18 Takeda
5.18.1 Takeda Profile
5.18.2 Takeda Main Business
5.18.3 Takeda Pharmaceutical Drugs Products, Services and Solutions
5.18.4 Takeda Pharmaceutical Drugs Revenue (US$ Million) & (2018-2024)
5.18.5 Takeda Recent Developments
5.19 Boehringer Ingelheim
5.19.1 Boehringer Ingelheim Profile
5.19.2 Boehringer Ingelheim Main Business
5.19.3 Boehringer Ingelheim Pharmaceutical Drugs Products, Services and Solutions
5.19.4 Boehringer Ingelheim Pharmaceutical Drugs Revenue (US$ Million) & (2018-2024)
5.19.5 Boehringer Ingelheim Recent Developments
5.20 Takeda
5.20.1 Takeda Profile
5.20.2 Takeda Main Business
5.20.3 Takeda Pharmaceutical Drugs Products, Services and Solutions
5.20.4 Takeda Pharmaceutical Drugs Revenue (US$ Million) & (2018-2024)
5.20.5 Takeda Recent Developments
6 North America
6.1 North America Pharmaceutical Drugs Market Size by Country (2018-2029)
6.2 the United States
6.3 Canada
7 Europe
7.1 Europe Pharmaceutical Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pharmaceutical Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pharmaceutical Drugs Market Dynamics
11.1 Pharmaceutical Drugs Industry Trends
11.2 Pharmaceutical Drugs Market Drivers
11.3 Pharmaceutical Drugs Market Challenges
11.4 Pharmaceutical Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Pharmaceutical Drugs Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Pharmaceutical Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Pharmaceutical Drugs Market Size Share by Region (2018-2024)
Table 4. Global Pharmaceutical Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Pharmaceutical Drugs Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Pharmaceutical Drugs Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Pharmaceutical Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Pharmaceutical Drugs Revenue Market Share by Type (2018-2024)
Table 9. Global Pharmaceutical Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Pharmaceutical Drugs Revenue Market Share by Type (2024-2029)
Table 11. North America Pharmaceutical Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Pharmaceutical Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Pharmaceutical Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Pharmaceutical Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Pharmaceutical Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Pharmaceutical Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Pharmaceutical Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Pharmaceutical Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Pharmaceutical Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Pharmaceutical Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Pharmaceutical Drugs Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Pharmaceutical Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Pharmaceutical Drugs Revenue Market Share by Application (2018-2024)
Table 24. Global Pharmaceutical Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Pharmaceutical Drugs Revenue Market Share by Application (2024-2029)
Table 26. North America Pharmaceutical Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Pharmaceutical Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Pharmaceutical Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Pharmaceutical Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Pharmaceutical Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Pharmaceutical Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Pharmaceutical Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Pharmaceutical Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Pharmaceutical Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Pharmaceutical Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Pharmaceutical Drugs Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Pharmaceutical Drugs Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Drugs as of 2022)
Table 39. Date of Key Players Enter into Pharmaceutical Drugs Market
Table 40. Global Pharmaceutical Drugs Key Players Headquarters and Area Served
Table 41. Pharmaceutical Drugs Product Solution and Service
Table 42. Global Pharmaceutical Drugs Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Pfizer Basic Information List
Table 45. Pfizer Description and Business Overview
Table 46. Pfizer Pharmaceutical Drugs Products, Services and Solutions
Table 47. Revenue (US$ Million) in Pharmaceutical Drugs Business of Pfizer (2018-2024)
Table 48. Pfizer Recent Developments
Table 49. Roche Basic Information List
Table 50. Roche Description and Business Overview
Table 51. Roche Pharmaceutical Drugs Products, Services and Solutions
Table 52. Revenue (US$ Million) in Pharmaceutical Drugs Business of Roche (2018-2024)
Table 53. Roche Recent Developments
Table 54. Sanofi Basic Information List
Table 55. Sanofi Description and Business Overview
Table 56. Sanofi Pharmaceutical Drugs Products, Services and Solutions
Table 57. Revenue (US$ Million) in Pharmaceutical Drugs Business of Sanofi (2018-2024)
Table 58. Sanofi Recent Developments
Table 59. Johnson & Johnson Basic Information List
Table 60. Johnson & Johnson Description and Business Overview
Table 61. Johnson & Johnson Pharmaceutical Drugs Products, Services and Solutions
Table 62. Revenue (US$ Million) in Pharmaceutical Drugs Business of Johnson & Johnson (2018-2024)
Table 63. Johnson & Johnson Recent Developments
Table 64. Merck & Co. (MSD) Basic Information List
Table 65. Merck & Co. (MSD) Description and Business Overview
Table 66. Merck & Co. (MSD) Pharmaceutical Drugs Products, Services and Solutions
Table 67. Revenue (US$ Million) in Pharmaceutical Drugs Business of Merck & Co. (MSD) (2018-2024)
Table 68. Merck & Co. (MSD) Recent Developments
Table 69. Novartis Basic Information List
Table 70. Novartis Description and Business Overview
Table 71. Novartis Pharmaceutical Drugs Products, Services and Solutions
Table 72. Revenue (US$ Million) in Pharmaceutical Drugs Business of Novartis (2018-2024)
Table 73. Novartis Recent Developments
Table 74. AbbVie Basic Information List
Table 75. AbbVie Description and Business Overview
Table 76. AbbVie Pharmaceutical Drugs Products, Services and Solutions
Table 77. Revenue (US$ Million) in Pharmaceutical Drugs Business of AbbVie (2018-2024)
Table 78. AbbVie Recent Developments
Table 79. Gilead Sciences Basic Information List
Table 80. Gilead Sciences Description and Business Overview
Table 81. Gilead Sciences Pharmaceutical Drugs Products, Services and Solutions
Table 82. Revenue (US$ Million) in Pharmaceutical Drugs Business of Gilead Sciences (2018-2024)
Table 83. Gilead Sciences Recent Developments
Table 84. GlaxoSmithKline (GSK) Basic Information List
Table 85. GlaxoSmithKline (GSK) Description and Business Overview
Table 86. GlaxoSmithKline (GSK) Pharmaceutical Drugs Products, Services and Solutions
Table 87. Revenue (US$ Million) in Pharmaceutical Drugs Business of GlaxoSmithKline (GSK) (2018-2024)
Table 88. GlaxoSmithKline (GSK) Recent Developments
Table 89. Amgen Basic Information List
Table 90. Amgen Description and Business Overview
Table 91. Amgen Pharmaceutical Drugs Products, Services and Solutions
Table 92. Revenue (US$ Million) in Pharmaceutical Drugs Business of Amgen (2018-2024)
Table 93. Amgen Recent Developments
Table 94. AstraZeneca Basic Information List
Table 95. AstraZeneca Description and Business Overview
Table 96. AstraZeneca Pharmaceutical Drugs Products, Services and Solutions
Table 97. Revenue (US$ Million) in Pharmaceutical Drugs Business of AstraZeneca (2018-2024)
Table 98. AstraZeneca Recent Developments
Table 99. Bristol-Myers Squibb Basic Information List
Table 100. Bristol-Myers Squibb Description and Business Overview
Table 101. Bristol-Myers Squibb Pharmaceutical Drugs Products, Services and Solutions
Table 102. Revenue (US$ Million) in Pharmaceutical Drugs Business of Bristol-Myers Squibb (2018-2024)
Table 103. Bristol-Myers Squibb Recent Developments
Table 104. Eli Lilly Basic Information List
Table 105. Eli Lilly Description and Business Overview
Table 106. Eli Lilly Pharmaceutical Drugs Products, Services and Solutions
Table 107. Revenue (US$ Million) in Pharmaceutical Drugs Business of Eli Lilly (2018-2024)
Table 108. Eli Lilly Recent Developments
Table 109. Teva Basic Information List
Table 110. Teva Description and Business Overview
Table 111. Teva Pharmaceutical Drugs Products, Services and Solutions
Table 112. Revenue (US$ Million) in Pharmaceutical Drugs Business of Teva (2018-2024)
Table 113. Teva Recent Developments
Table 114. Bayer Basic Information List
Table 115. Bayer Description and Business Overview
Table 116. Bayer Pharmaceutical Drugs Products, Services and Solutions
Table 117. Revenue (US$ Million) in Pharmaceutical Drugs Business of Bayer (2018-2024)
Table 118. Bayer Recent Developments
Table 119. Novo Nordisk Basic Information List
Table 120. Novo Nordisk Description and Business Overview
Table 121. Novo Nordisk Pharmaceutical Drugs Products, Services and Solutions
Table 122. Revenue (US$ Million) in Pharmaceutical Drugs Business of Novo Nordisk (2018-2024)
Table 123. Novo Nordisk Recent Developments
Table 124. AbbVie Basic Information List
Table 125. AbbVie Description and Business Overview
Table 126. AbbVie Pharmaceutical Drugs Products, Services and Solutions
Table 127. Revenue (US$ Million) in Pharmaceutical Drugs Business of AbbVie (2018-2024)
Table 128. AbbVie Recent Developments
Table 129. Takeda Basic Information List
Table 130. Takeda Description and Business Overview
Table 131. Takeda Pharmaceutical Drugs Products, Services and Solutions
Table 132. Revenue (US$ Million) in Pharmaceutical Drugs Business of Takeda (2018-2024)
Table 133. Takeda Recent Developments
Table 134. Boehringer Ingelheim Basic Information List
Table 135. Boehringer Ingelheim Description and Business Overview
Table 136. Boehringer Ingelheim Pharmaceutical Drugs Products, Services and Solutions
Table 137. Revenue (US$ Million) in Pharmaceutical Drugs Business of Boehringer Ingelheim (2018-2024)
Table 138. Boehringer Ingelheim Recent Developments
Table 139. Takeda Basic Information List
Table 140. Takeda Description and Business Overview
Table 141. Takeda Pharmaceutical Drugs Products, Services and Solutions
Table 142. Revenue (US$ Million) in Pharmaceutical Drugs Business of Takeda (2018-2024)
Table 143. Takeda Recent Developments
Table 144. North America Pharmaceutical Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 145. North America Pharmaceutical Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 146. Europe Pharmaceutical Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 147. Europe Pharmaceutical Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 148. Asia-Pacific Pharmaceutical Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 149. Asia-Pacific Pharmaceutical Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 150. Asia-Pacific Pharmaceutical Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 151. Asia-Pacific Pharmaceutical Drugs Market Share by Region (2018-2024)
Table 152. Asia-Pacific Pharmaceutical Drugs Market Share by Region (2024-2029)
Table 153. Latin America Pharmaceutical Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 154. Latin America Pharmaceutical Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 155. Latin America Pharmaceutical Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 156. Middle East & Africa Pharmaceutical Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 157. Middle East & Africa Pharmaceutical Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 158. Middle East & Africa Pharmaceutical Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 159. Pharmaceutical Drugs Market Trends
Table 160. Pharmaceutical Drugs Market Drivers
Table 161. Pharmaceutical Drugs Market Challenges
Table 162. Pharmaceutical Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical Drugs Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Pharmaceutical Drugs Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Pharmaceutical Drugs Market Share by Regions: 2022 VS 2029
Figure 4. Global Pharmaceutical Drugs Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Pharmaceutical Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Pharmaceutical Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Pharmaceutical Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Pharmaceutical Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Pharmaceutical Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Brand Drugs
Figure 11. Global Brand Drugs Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Generic Drug
Figure 13. Global Generic Drug Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global Pharmaceutical Drugs Market Size Share by Type: 2022 & 2029
Figure 15. North America Pharmaceutical Drugs Revenue Market Share by Type (2018-2029)
Figure 16. Europe Pharmaceutical Drugs Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific Pharmaceutical Drugs Revenue Market Share by Type (2018-2029)
Figure 18. Latin America Pharmaceutical Drugs Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa Pharmaceutical Drugs Revenue Market Share by Type (2018-2029)
Figure 20. Hospital Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Clinic Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Other Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Global Pharmaceutical Drugs Market Size Share by Application: 2022 & 2029
Figure 24. North America Pharmaceutical Drugs Revenue Market Share by Application (2018-2029)
Figure 25. Europe Pharmaceutical Drugs Revenue Market Share by Application (2018-2029)
Figure 26. Asia-Pacific Pharmaceutical Drugs Revenue Market Share by Application (2018-2029)
Figure 27. Latin America Pharmaceutical Drugs Revenue Market Share by Application (2018-2029)
Figure 28. Middle East and Africa Pharmaceutical Drugs Revenue Market Share by Application (2018-2029)
Figure 29. Pharmaceutical Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players Pharmaceutical Drugs Market Share in 2022
Figure 31. North America Pharmaceutical Drugs Market Share by Country (2018-2029)
Figure 32. the United States Pharmaceutical Drugs Market Size (2018-2029) & (US$ Million)
Figure 33. Canada Pharmaceutical Drugs Market Size (2018-2029) & (US$ Million)
Figure 34. Germany Pharmaceutical Drugs Market Size (2018-2029) & (US$ Million)
Figure 35. France Pharmaceutical Drugs Market Size (2018-2029) & (US$ Million)
Figure 36. U.K. Pharmaceutical Drugs Market Size (2018-2029) & (US$ Million)
Figure 37. Italy Pharmaceutical Drugs Market Size (2018-2029) & (US$ Million)
Figure 38. Russia Pharmaceutical Drugs Market Size (2018-2029) & (US$ Million)
Figure 39. Nordic Countries Pharmaceutical Drugs Market Size (2018-2029) & (US$ Million)
Figure 40. Asia-Pacific Pharmaceutical Drugs Market Share by Region (2018-2029)
Figure 41. China Pharmaceutical Drugs Market Size (2018-2029) & (US$ Million)
Figure 42. Japan Pharmaceutical Drugs Market Size (2018-2029) & (US$ Million)
Figure 43. South Korea Pharmaceutical Drugs Market Size (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Pharmaceutical Drugs Market Size (2018-2029) & (US$ Million)
Figure 45. India Pharmaceutical Drugs Market Size (2018-2029) & (US$ Million)
Figure 46. Australia Pharmaceutical Drugs Market Size (2018-2029) & (US$ Million)
Figure 47. Latin America Pharmaceutical Drugs Market Share by Country (2018-2029)
Figure 48. Mexico Pharmaceutical Drugs Market Size (2018-2029) & (US$ Million)
Figure 49. Brazil Pharmaceutical Drugs Market Size (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Pharmaceutical Drugs Market Share by Country (2018-2029)
Figure 51. Turkey Pharmaceutical Drugs Market Size (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Pharmaceutical Drugs Market Size (2018-2029) & (US$ Million)
Figure 53. UAE Pharmaceutical Drugs Market Size (2018-2029) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report